Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14980448rdf:typepubmed:Citationlld:pubmed
pubmed-article:14980448lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C1948059lld:lifeskim
pubmed-article:14980448lifeskim:mentionsumls-concept:C1720529lld:lifeskim
pubmed-article:14980448pubmed:issue3lld:pubmed
pubmed-article:14980448pubmed:dateCreated2004-2-24lld:pubmed
pubmed-article:14980448pubmed:abstractTextThe truncated myc and max proteins, only containing basic regions and helix-loop-helix/zipper (b/HLH/Zip) regions were over-expressed in E. coli and used for the determination of the binding constant and of the inhibitory mechanism on myc-max (or max-max)-DNA complex formation. The association kinetic constants (k(1) and k(-1)) of truncated max-max or myc-max dimer and DNA were determined as k(1)=(1.7+/-0.6)x10(5) M(-1) s(-1), k(-1)=(3.4+/-1.2)x10(-2) s(-1) for max-max and DNA or k(1)=(2.1+/-0.7)x10(5) M(-1) s(-1), k(-1)=(3.2+/-1.4)x10(-2) s(-1) for myc-max and DNA. The equilibrium binding constant (K(1)) was determined using these kinetic parameters [K(XXD)=(7.8+/-2.6)x10(6) M(-1) for max-max and DNA or K(XYD)=(6.9+/-2.2)x10(6) M(-1) for myc-max and DNA]. The binding constants of myc-max or max-max dimer formation were K(XX)=(2.6+/-0.9)x10(5) M(-1) or K(XY)=(1.3+/-0.4)x10(4) M(-1), respectively. When truncated proteins were used, the max-max dimer formation was easier than the myc-max dimer formation, contrary to the physiologically determined case. This leads us to deduce that domains other than b/HLH/Zip are very important for the transcriptional regulatory activity in physiological conditions. The truncated myc and max proteins, which were expressed in E. coli and contained only b/HLH/Zip regions were also used for the screening of inhibitors of myc-max-DNA complex formation. A synthesized curcuminoid, 1,7-bis(4-methyl-3-nitrophenyl)-1,6-heptadiene-3,5-dione (curcuminoid 004), showed the most potent inhibition out of the synthesized curcuminoids, in competition with DNA. The dissociation constant of max-max dimer and the inhibitor was 9 microM, when investigated using in vitro expressed b/HLH/Zip dimer proteins. The curcuminoid 004 showed an inhibitory effect on the binding of myc-max protein to the E-box element in SNU16 cells, and suppressed the expression of myc target genes including ornithine decarboxylase (ODC), cdc25a and c-myc in myc over-expressed human stomach cancer cell line SNU16.lld:pubmed
pubmed-article:14980448pubmed:languageenglld:pubmed
pubmed-article:14980448pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:citationSubsetIMlld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14980448pubmed:statusMEDLINElld:pubmed
pubmed-article:14980448pubmed:monthFeblld:pubmed
pubmed-article:14980448pubmed:issn0006-3002lld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:YangChul-HakC...lld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:HahmEun-Ryeon...lld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:ParkChihoonClld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:ChungSunahSlld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:ParkSeyeonSlld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:KimKyung-MeeK...lld:pubmed
pubmed-article:14980448pubmed:authorpubmed-author:JungKyung-Cha...lld:pubmed
pubmed-article:14980448pubmed:issnTypePrintlld:pubmed
pubmed-article:14980448pubmed:day24lld:pubmed
pubmed-article:14980448pubmed:volume1670lld:pubmed
pubmed-article:14980448pubmed:ownerNLMlld:pubmed
pubmed-article:14980448pubmed:authorsCompleteYlld:pubmed
pubmed-article:14980448pubmed:pagination217-28lld:pubmed
pubmed-article:14980448pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:meshHeadingpubmed-meshheading:14980448...lld:pubmed
pubmed-article:14980448pubmed:year2004lld:pubmed
pubmed-article:14980448pubmed:articleTitleDetermination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.lld:pubmed
pubmed-article:14980448pubmed:affiliationSamsung Medical Center, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, South Korea.lld:pubmed
pubmed-article:14980448pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14980448pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14980448lld:pubmed